Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (81-90 of 456) with videos related to

Pageof 46
Sort By:
Journal of the National Cancer Institute|June 21, 1989
Multidrug resistance: P-glycoprotein and its allies--the elusive foesB A Chabner, A Fojo
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
MDR1 inhibition: less resistance or less relevance?L A Garraway, B Chabner
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
Progress and perspectives of systemic anticancer treatmentB A Chabner, E Reed
The Journal of Clinical Investigation|September 1, 1983
Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductaseJ Jolivet, B A Chabner
JAMA|May 16, 1990
OncologyM Rothenberg, B A Chabner
The Oncologist|July 1, 1999
Schwartz Center Rounds. A Staff Dialogue on Phase I Trials: Psychosocial Issues Faced by Patients, Their Families, and CaregiversLintz, Penson, Chabner, et al.
Science (New York, N.Y.)|May 14, 1993
Funding for gene therapyB A Chabner, R Levy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Reversal of multidrug resistanceB A Chabner, W Wilson
The Oncologist|February 4, 2012
Call it cancerBruce A Chabner, Matthew Smith
The Oncologist|August 2, 2011
Patient navigator programs, cancer disparities, and the patient protection and affordable care actBeverly Moy, Bruce A Chabner
Pageof 46

Showing results (81-90 of 456) with videos related to

Sort By:
Pageof 46
Journal of the National Cancer Institute|June 21, 1989
Multidrug resistance: P-glycoprotein and its allies--the elusive foesB A Chabner, A Fojo
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
MDR1 inhibition: less resistance or less relevance?L A Garraway, B Chabner
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
Progress and perspectives of systemic anticancer treatmentB A Chabner, E Reed
The Journal of Clinical Investigation|September 1, 1983
Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductaseJ Jolivet, B A Chabner
JAMA|May 16, 1990
OncologyM Rothenberg, B A Chabner
The Oncologist|July 1, 1999
Schwartz Center Rounds. A Staff Dialogue on Phase I Trials: Psychosocial Issues Faced by Patients, Their Families, and CaregiversLintz, Penson, Chabner, et al.
Science (New York, N.Y.)|May 14, 1993
Funding for gene therapyB A Chabner, R Levy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Reversal of multidrug resistanceB A Chabner, W Wilson
The Oncologist|February 4, 2012
Call it cancerBruce A Chabner, Matthew Smith
The Oncologist|August 2, 2011
Patient navigator programs, cancer disparities, and the patient protection and affordable care actBeverly Moy, Bruce A Chabner
Pageof 46